News | RIVM

RIVM formulates criteria for R&D of sustainable pharmaceuticals

As part of an international research project, RIVM has formulated criteria for R&D of sustainable new pharmaceuticals. These GREENER criteria are an important first step to develop pharmaceuticals that do not impact the environment..

Number of STI tests at sexual health centres are rising again

In 2021, more than 138,000 people were tested for sexually transmitted infections (STIs) at a centre for sexual health.

More STI tests conducted by Sexual Health Centres

In 2021, more people visited a Sexual Health Centre (SHC) to get tested for sexually transmitted infections (STIs) than in 2020. This figure is still lower than in 2019, the year before the coronavirus outbreak.

Towards a sustainable, healthy future for everyone: EU project INHERIT offers policy solutions

Today, on 10 December a policy toolkit will be presented at the final conference of the European four-year research project INHERIT.

Young people who use screens before sleeping have more sleep problems

Young people (13-18 years) who use light-emitting screens daily in the hour before going to sleep have more sleep problems.

Health and Well-being through Effective Blue-Green Space Design and Governance

During World Water Week (August 26 – 31, 2018), the Dutch National Institute for Public Health and the Environment, RIVM, is facilitating a session on Health and Well-being through effective Blue-G

More gonorrhoea, syphilis and chlamydia at Dutch STI clinics

An increasing number of clients tested at a Dutch STI clinic for a sexually transmitted infection (STI) is diagnosed with gonorrhoea, syphilis and chlamydia.

The number of STI tests keeps increasing

The number of clients tested for sexually transmitted infections (STIs) at Dutch STI clinics has increased since 2004.

Is screening for sexually transmitted infections as part of HIV care cost-effective in the Netherlands?

Routine screening for anorectal chlamydia among HIV-positive men who have sex with men (MSM) could avert further spread of chlamydia and HIV in the total MSM population.

Regional differences in testing rates underestimate incidence of LGV epidemic

Until 2003, Lymphogranuloma venereum (LGV), an aggressive form of chlamydia, was considered to be a rare tropical disease, endemic to Africa, Asia and the Caribbean.